Sitafloxacin

Generic Name
Sitafloxacin
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C38H42Cl2F4N6O9
CAS Number
163253-35-8
Unique Ingredient Identifier
9TD681796G
Indication

用于治疗严重的、耐药菌引起的难治性细菌感染性疾病。如咽炎、喉炎、扁桃体炎、急性支气管炎、感染性肺炎、慢性呼吸系统疾病的继发感染;膀胱炎、肾盂肾炎、尿道炎;宫颈炎;中耳炎、鼻窦炎;牙周炎、冠周炎等。

Associated Conditions
Bacterial Pneumonia, Bacterial Sinusitis, Cervicitis, Cystitis, Otitis Media (OM), Periodontitis, Tonsillitis, Urethritis
Associated Therapies
-

A Study to Evaluate the Efficacy and Safety of Sitafloxacin in Adult Subjects With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

First Posted Date
2022-06-01
Last Posted Date
2024-04-10
Lead Sponsor
Daiichi Sankyo
Target Recruit Count
268
Registration Number
NCT05400369
Locations
🇨🇳

The First Affiliated Hospital of Dalian Medical University, Dalian, China

🇨🇳

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

🇨🇳

The Third Xiangya Hospital of Central South University, Changsha, China

and more 15 locations

Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients

First Posted Date
2016-04-06
Last Posted Date
2023-03-08
Lead Sponsor
Khon Kaen University
Target Recruit Count
30
Registration Number
NCT02729116
Locations
🇹🇭

Khon Kaen University, Ban Khanaen, Khonkaen, Thailand

Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Escherichia Coli

First Posted Date
2015-09-02
Last Posted Date
2015-09-02
Lead Sponsor
Mahidol University
Target Recruit Count
96
Registration Number
NCT02537847
Locations
🇹🇭

Faculty of Medicine Ramathibodi Hospital, Bangkok, Thailand

© Copyright 2024. All Rights Reserved by MedPath